This status is rare as we have typically observed, across the breast epithelial and breast cancer samples we have profiled, that EGFR and ERBB2 activity are often jointly active or inactive, consistent with the obligate dimer behavior of ERBB2. This evidence concerns the gene ERBB2 and breast carcinoma.